Oral vinorelbine plus cisplatin with concomitant radiotherapy as induction therapy for stage III non-small cell lung cancer: Results of a single-arm prospective cohort study.
Ping-Chih HsuJohn Wen-Chang ChangChun-Chieh WangChen-Te WuYu-Ching LinChih-Liang WangTin-Yu LinShih-Hong LiYi-Chen WuAllen Chung-Cheng HuangCheng-Ta YangChien-Ying LiuChih-Hung ChenPublished in: Thoracic cancer (2019)
CCRT with the weekly regimen of oral vinorelbine plus triweekly cisplatin was effective and safe for stage III NSCLC.